We have previously shown that nerve growth factor (NGF) withdrawal-induced death requires the activity of the small GTP-binding protein Cdc42 and that overexpression of an active form of Cdc42 is sufficient to mediate neuronal apoptosis via activation of the c-Jun pathway. Recently, a new mitogen-activated protein (MAP) kinase kinase kinase, apoptosis signal-regulating kinase 1 (ASK1) which activates both the c-Jun N-terminal kinase (JNK) and p38 MAP kinase pathways and plays pivotal roles in tumor necrosis factor-and Fas-induced apoptosis, has been identified. Therefore, we investigated the role of ASK1 in neuronal apoptosis by using rat pheochromocytoma (PC12) neuronal cells and primary rat sympathetic neurons (SCGs). Overexpression of ASK1-⌬N, a constitutively active mutant of ASK1, activated JNK and induced apoptosis in differentiated PC12 cells and SCG neurons. Moreover, in differentiated PC12 cells, NGF withdrawal induced a four-to fivefold increase in the activity of endogenous ASK1. Finally, expression of a kinase-inactive ASK1 significantly blocked both NGF withdrawal-and Cdc42-induced death and activation of c-jun. Taken together, these results demonstrate that ASK1 is a crucial element of NGF withdrawal-induced activation of the Cdc42-c-Jun pathway and neuronal apoptosis.
Programmed cell death is an active process occurring during both normal maturation of the nervous system and pathological situations such as neurodegenerative diseases and stroke (5, 15, 19, 25, 26) . Various phenotypes of programmed cell death have been described, including apoptosis with chromatin and cytoplasmic condensation and fragmentation (7, 28, 29) . Neuronal apoptosis and survival are regulated by two major kinds of cell surface molecules, which respond to external stimuli: the Trk molecules, which promote differentiation and survival of specific neuronal populations, and the p75 neurotrophin receptor, which can mediate apoptosis upon ligand binding. Ultimately, extracellular signals are transmitted into the activation of either anti-or proapoptotic genes. Some of the specific regulatory pathways involved in transducing these signals are begun to be understood. Indeed, activation of the stress-activated protein kinases (stress-activated protein kinase/c-Jun N-terminal kinase [SAPK/JNK] and/or p38 mitogen-activated protein kinase [MAPK] ) pathway has been observed soon after induction of apoptosis by nerve growth factor (NGF) withdrawal in rat pheochromocytoma PC12 cells (38) , in rat sympathetic neurons (superior cervical ganglion neurons [SCGs] ) (8, 14) , in rat cerebellar granule neurons (37) , and in embryonic motoneurons (21) . Moreover, phosphorylation of c-Jun and activation of SAPK/JNK have been observed after neuronal injury in the adult rat brain (16) . Recently, we have shown that activated mutants of the Rho-like GTPases, Cdc42 and Rac1, induced apoptosis of SCGs by activating the c-Jun transcriptional pathway (1) . More importantly, Cdc42 was shown to be required for NGF withdrawal-induced cell death (1) . Therefore, a comprehensive knowledge of the upstream regulators of the JNK pathway is needed to provide insights about possible mediators of neuronal apoptosis induced by both NGF withdrawal and Cdc42.
Candidates for activation of the JNK and p38 MAPK pathways have been identified and include the p21-activated kinases (3, 12) mixed-lineage kinase 3 (23, 31) , MEKK1 and MEKK4 (10, 13) , POSH (30) , and the recently identified apoptosis signal-regulating kinase 1 (ASK1) (18, 36) . The ubiquitously expressed serine/threonine kinase ASK1 is a MAPK kinase kinase (MAPKKK) that activates both SEK1 (also termed MKK4 or JNKK1)-JNK and MKK3/MKK6-p38 kinase pathways. Overexpression of an activated ASK1 mutant in epithelial cells induced cell death, which exhibited the characteristics of apoptosis (18, 27) . ASK1 was activated upon treatment with tumor necrosis factor (24) or with an anti-Fas antibody (4) , and a kinase-inactive mutant of ASK1 blocked tumor necrosis factor-and Fas-induced apoptosis in Jurkat cells and HeLa cells, respectively (4, 18) . These studies strongly suggested that ASK1 plays a central role in the mechanisms of stress-and cytokine-induced apoptosis and prompted us to look at its role in our models of neuronal cell death.
Herein, we report that an active ASK1 induces death by apoptosis of both a neuronal cell line (the rat pheochromocytoma PC12 cells) and rat primary sympathetic neurons (SCGs). Induction of cell death was accompanied by an increase in JNK Tetracycline system. The hygromycin resistance gene derived from pBHMr and the neomycin resistance gene derived from pABWN were each subcloned into the pTet-tTAK plasmid (Gibco BRL) and the pTet-Splice (Gibco BRL) and named pTet-tTAK-hyg and pTet-Splice-neo, respectively. The cDNAs for HAtagged ASK1-⌬N or HA-tagged ASK1-KM were then subcloned into pTetSplice-neo. The pTet-tTAK-hyg plasmid was transfected into PC12 cells by using DMRIE-C (Gibco BRL) as specified by the manufacturer. Cells were selected with 240 U of hygromycin (Wako) per ml, and several hygromycin-resistant stable clones were established. A clone termed PC12-pTet-tTAK-hyg was further transfected with pTet-Splice-neo-based expression vectors for HA-ASK1-⌬N or HA-ASK1-KM. After selection with 400 g of neomycin (Geneticin; Gibco BRL) per ml and 240 U of hygromycin per ml, the doubly resistant clones were established and analyzed for the expression of HA-tagged ASK1 mutant proteins by Western blot analysis. The cells were maintained in DMEM supplemented with 10% FCS, 10% heat-inactivated horse serum, 100 U of penicillin G per ml, 0.5 g of tetracycline per ml, 120 U of hygromycin per ml, and 200 g of neomycin per ml.
Adenovirus vectors. Recombinant adenoviruses were constructed as described previously (27) . Briefly, HA-tagged ASK1 cDNA mutants and ␤-galactosidase cDNA were subcloned into the SwaI site of the pAxCAwt cassette cosmid, which is defective in the adenovirus E1A, E1B, and E3 regions. Each cosmid, bearing the expression unit and the adenovirus DNA-terminal protein complex, were cotransfected into the E1 transcomplementing cell line 293. The recombinant adenoviruses generated by homologous recombination were isolated, and the insertion of ASK1 cDNAs was confirmed by restriction endonuclease digestion. High-titer stocks of recombinant adenoviruses were grown in 293 cells and purified. Infection of PC12 cells with the recombinant adenoviruses was done at a multiplicity of infection (MOI) of 100 PFU/cell (or as otherwise indicated); in these infections, adenovirus vectors can transduce nearly 100% of PC12 cells as determined by ␤-galactosidase (␤-gal) staining (T. Kanamoto and H. Ichijo unpublished observation). The presence of a comparable level of protein expression for each ASK1 construct was confirmed by immunoblotting with anti-HA antibody (data not shown).
DNA fragmentation analysis. NGF-differentiated PC12 cells were infected with adenovirus vectors expressing ␤-gal or ASK1-⌬N and were maintained in the presence of NGF. At given times, small fragmented cytoplasmic DNA was isolated as previously described (18) . Briefly, cells were lysed with 200 l of a buffer containing 20 mM Tris-HCl (pH 7.5), 10 mM EDTA, and 0.5% Triton X-100. Cell extracts were clarified by centrifugation at 15,000 ϫ g for 5 min. The lysates were then incubated with 0.2 mg of proteinase K per ml-0.1 mg of RNase A per ml at 42°C for 1 h. The DNA was purified by ethanol precipitation after phenol-chloroform extraction and analyzed by agarose gel electrophoresis (2% agarose).
Microinjection and survival assay. Sympathetic neurons were microinjected as described previously (1) . All plasmids were purified on a double cesium chloride gradient and resuspended in H 2 O. The injection mix constituted of 50% phosphate-buffered saline and 5 mg of 70,000-Da Texas Red-dextran (Molecular Probes, Eugene, Oreg.) per ml (survival assay) or 2.5 mg of purified guinea pig immunoglobulin G (IgG) (Sigma) per ml (immunostaining analysis) to observe the injected cells. At 4 h after injection, the neurons were refed as described above. The percent survival was assessed as previously described (1) .
Immunofluorescence staining. For the c-jun-CAT reporter gene assay, SCG neurons were injected with 0.05 mg of c-jun CAT per ml in the presence or absence of a plasmid of interest, together with guinea pig IgG to detect the injected cells. At 24 h after injection, the cells were fixed in 3.7% formaldehyde, permeabilized with 0.5% Triton X-100 in PBS, and blocked with 50% goat serum. The neurons were stained with a polyclonal anti-CAT antibody diluted 1:100 and finally with a fluorescein isothiocyanate-conjugated secondary antibody and a rhodamine-conjugated anti-guinea pig IgG antibody (Stratech Scientific) to detect the injected cells. Only the cells showing a clear increase over the background staining were scored positive. To detect phospho-c-Jun, the cells were fixed with 3% paraformaldehyde, permeabilised with 0.5% Triton X-100, and blocked as described above. They were then stained with a specific phosphoc-Jun antibody and with the appropriate secondary antibodies as described above. To examine nuclear morphology, cells were stained with Hoechst dye (Hoechst 33342; Sigma) at 10 g/ml.
RESULTS
Activated ASK1 induces neuronal apoptosis. To investigate the role of ASK1 in neuronal cell death, we examined the effect of ASK1-⌬N, a constitutively active mutant of ASK1 (27) , in differentiated PC12 cells and in rat primary sympathetic neurons. PC12 cells were cultured in the presence of 50 ng of NGF per ml for 7 days and then infected with recombinant adenoviruses encoding ␤-gal or HA-tagged ASK1-⌬N. The efficiency of the adenovirus infection was nearly 100% as determined by the control staining for ␤-gal infectant (data not shown), suggesting that recombinant adenoviruses provide a useful system VOL. 20, 2000 ASK1 IN NEURONAL APOPTOSIS 197 to express exogenous genes in differentiated PC12 cells. The level of expression of ASK1-⌬N was determined by immunoblotting with a monoclonal anti-HA antibody and was first detected 12 h after infection (Fig. 1A) . The viability of the infected cells was examined by phase-contrast microscopy 48 h after infection. Expression of ASK1-⌬N, but not of a control ␤-gal, clearly induced cell death, with morphologically apoptotic features including membrane blebbing, pyknosis, and cell body condensation even in the presence of NGF (Fig. 1B) . To further characterize the death induced by ASK1-⌬N, we performed a DNA ladder analysis. The cytoplasmic small fragmented DNA was extracted after infection and analyzed by agarose gel electrophoresis. Genomic DNA fragmentation was first observed 24 h after infection (Fig. 1C) in the cells overexpressing ASK1-⌬N but not in those expressing the control ␤-gal.
We next extended our study of the role of ASK1 to primary rat SCG neurons, cultured for 6 days in the presence of NGF, were microinjected at 0.3 mg/ml with an empty expression vector (control) or of the different ASK1 mutants including ASK1-⌬N and ASK1-KR, a kinase-inactive mutant in which Lys 709 was replaced by Arg. The percent survival was then assessed 48 h after injection. Figure 1D shows that ASK1-⌬N significantly decreased the viability of the SCG neurons whereas the empty vector and the kinase-inactive mutant ASK1-KR had no effect. The cell death induced by ASK1 exhibited the characteristics of an apoptotic mechanism where the nuclei were clearly pyknotic and stained positive for terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) analysis (data not shown). Taken together, these results demonstrate that ASK1 has a proapoptotic activity in neuronal cells and that its kinase activity is required for the induction of cell death.
ASK1 is required for NGF withdrawal-induced death. When differentiated, PC12 cells are dependent on NGF and undergo apoptosis following NGF deprivation. To examine whether ASK1 is involved in NGF withdrawal-induced death, we have established a stable PC12 cell line expressing HA-tagged ASK1-KM (PC12-ASK1-KM cells), another kinase-inactive mutant of ASK1, in which Lys 709 was replaced by Met. The expression of ASK1 is under the control of a tetracycline- repressible promoter (see Materials and Methods). After removal of tetracycline from the culture medium, the expression of ASK1-KM was turned on and was readily detectable by Western blot analysis with an anti-HA antibody ( Fig. 2A) . Notably, no leaky expression was detected in the presence of tetracycline, indicating that the tetracycline-repressible promoter was well controlled in this cell line. In the presence of tetracycline, PC12-ASK1-KM cells differentiated into sympathetic neuron-like cells by NGF treatment and were indistinguishable from the parental PC12 cells (Fig. 2B) . When the differentiated PC12-ASK1-KM cells were deprived of NGF but maintained in the presence of tetracycline, their viability significantly decreased (Fig. 2B and C) . In contrast, when NGF was withdrawn 24 h after induction of ASK1-KM by tetracycline removal, NGF withdrawal-induced cell death was partially but significantly inhibited at 48 h after NGF deprivation ( Fig. 2B and C) . Furthermore, to exclude the possibility that the effect of ASK1-KM in differentiated PC12-ASK1-KM cells was caused by a clonal variation, we also examined the effect of recombinant adenoviruses encoding HA-tagged ASK1-KR on parental PC12 cells as previously described. Briefly, the level of expression of ASK1-KR was determined by immunoblotting with a monoclonal anti-HA antibody (Fig. 3A) and the viability of the infected cells was examined by phase-contrast microscopy 48 h after infection. Similarly, expression of ASK1-KR, but not of ␤-gal, partially prevented cell death induced by NGF withdrawal (Fig. 3B) . These results strongly suggest that ASK1 is an important component of the death-signaling pathway mediated by NGF withdrawal in neuronal cells.
Finally, we determined whether ASK1 is a required component of the NGF withdrawal-induced death of SCG neurons. We microinjected increasing concentrations of ASK1-KR DNA into SCG neurons as well as an empty vector (negative control) and Bcl-2, a potent antiapoptotic protein (positive control). At 4 to 5 h after injection, the cells were deprived of NGF and the percent surviving cells was assessed 48 h later as explained in Materials and Methods. Although slightly less effective than Bcl-2, ASK1-KR protected SCG neurons from NGF withdrawal-induced death in a dose-dependent manner (Fig. 3C ). In addition, we looked at the effect of ASK1-KR on the nuclear morphology of the injected cells. SCGs were microinjected with 0.5 mg of either an empty expression vector or ASK1-KR per ml. The cells were removed from NGF and stained with Hoechst 33342 24 h later. Controls of uninjected cells, maintained in the presence or absence of NGF, were included. Figure 3D shows that blocking the ASK1 activity significantly decreased the number of cells displaying pyknotic nuclei. Taken together, these results confirm the involvement of ASK1 in mediating neuronal cell death induced by deprivation of trophic factors. ASK1 activity increases following NGF withdrawal. To determine whether ASK1 was activated upon NGF deprivation, we set out to measure the kinase activity of endogenous ASK1 in PC12 cells undergoing apoptosis. NGF-differentiated PC12 cells were deprived of NGF and further cultured in the presence or absence of NGF. The ASK1 kinase activity was determined by an immune complex-coupled kinase assay with GST-MKK6, GST-SAPK3/p38␥, and the ATF2 peptide as sequential substrates (27) . When the medium was replaced with NGF-containing medium, the kinase activity was unchanged (Fig. 4) . On the other hand, when the cells were deprived of NGF, a rapid increase in the kinase activity of ASK1, which peaked at 3 h after NGF deprivation, was observed (Fig. 4B) . These results strongly suggest that ASK1 kinase activity can be regulated after induction of cell death by NGF withdrawal.
Involvement of the ASK1-JNK pathway in the NGF withdrawal-induced signal. ASK1 has previously been shown to activate the JNK pathway in various cell types (4, 18, 35) . To determine whether this was the case in neuronal cells, we infected NGF-differentiated PC12 cells with a recombinant adenovirus encoding ASK1-⌬N or the ␤-gal control and measured JNK activity by an immune-complex JNK kinase assay at 6, 12, and 24 h after infection with a GST-c-Jun substrate. An increase in JNK activity was observed 24 h after infection (Fig.  5A ), which correlates with the kinetics of expression of ASK1-⌬N (Fig. 1A) . In addition, we investigated the activation of JNK for up to 45 h after infection (Fig. 5B) . Differentiated PC12 cells were infected with adenoviruses encoding control ␤-gal, ASK1-KM at 800 PFU/cell, and ASK1-⌬N at increasing MOIs. At 45 h later, the cells were lysed and subjected to Western blot analysis with specific phospho-JNK, JNK, and HA antibodies. The increase in JNK activation by ASK1-⌬N expression was dose dependent (Fig. 5B) whereas infection with the control ␤-gal or ASK1-KM, even at higher MOIs and for a longer period (45 h), had no effect on the level of JNK activation compared to the uninfected control (Fig. 5B) .
In parallel, we investigated the effect of ASK1 mutants on the level of phosphorylated c-Jun in SCG neurons in the presence or absence of NGF. Cells, microinjected with either the ASK1 mutants or an empty expression vector were labelled with a specific anti-phospho-c-Jun antibody. Cells injected with the empty control did not show any increase in phosphoc-Jun staining compared to the NGF control, whereas overexpression of ASK1-⌬N induced a 4.3-fold increase in the level of nuclearly phosphorylated c-Jun (Fig. 5C ). In addition, we ex- amined the effect of ASK1-KR on the increase in the level of phosphorylated c-Jun observed after NGF deprivation. We found that expression of a kinase dead mutant of ASK1 reduced dramatically the increase in phospho-c-Jun levels after NGF deprivation (Fig. 5C ). ASK1-KR had no effect on the phospho-c-Jun level when cells were maintained in the presence of NGF (Fig. 6B) . This suggests that ASK1 activity is crucial for the induction of phosphorylation of c-Jun after NGF withdrawal. We also examined whether ASK1 activated c-jun in SCG neurons by using a c-jun-CAT reporter gene, in which c-jun promoter sequences from Ϫ1600 to ϩ170 were subcloned upstream of the bacterial CAT gene (34) . SCG neurons were coinjected with ASK1-⌬N and a c-jun-CAT reporter gene together with guinea pig IgG as a marker for the injected cells. The cells were maintained in the presence of NGF and stained with an anti-CAT antibody 24 h after injection. About 10 to 20% of the cells injected with the c-jun-CAT gene alone expressed the CAT protein, whereas withdrawal of NGF triggered a three-to fourfold increase in the number of cells expressing the CAT protein showing the activation of c-Jun after NGF deprivation (Fig. 5D) (8) . Coinjection of ASK1-⌬N increased by twofold the percentage of cells expressing CAT (Fig. 5D) . The relatively weak CAT-inducing activity mediated by ASK1-⌬N may be caused by the underscore of CAT-positive cells because of the decreased viability of ASK1-⌬N-injected cells. Thus, c-jun appears to be activated by ASK1 in SCG neurons.
To investigate the requirement for ASK1 in the activation of c-Jun transcriptional pathway, we coinjected increasing concentration of ASK1-KR with c-jun-CAT into SCG neurons. At 4 h after injection, the cells were deprived of NGF, and they were stained for CAT expression 20 h later. Overexpression of ASK1-KR blocked the increase in the CAT expression that was observed after NGF withdrawal (Fig. 5D) . These results demonstrated not only that ASK1 is capable of activating the c-jun pathway in neuronal cells but also that it is required for the activation of this pathway by NGF withdrawal.
Finally, we investigated the effect of FLAG⌬169-Jun, a dominant negative mutant of c-Jun, that lacks the amino-terminal transactivation domain and also acts as a dominant inhibitor of AP-1 activity (14), on ASK1-induced apoptosis. SCG neurons were coinjected with 0.3 mg of ASK1-⌬N per ml and increasing concentrations of FLAG⌬169-Jun. Cell survival was assessed 48 h after the cells were refed with medium supplemented with NGF. Coexpression of FLAG⌬169-Jun efficiently blocked the induction of cell death by ASK1 (Fig. 5E) .
These results, together with the data that kinase-negative form of ASK1 protected NGF withdrawal-induced death both in PC12 cells and in SCG neurons (Fig. 2) , strongly suggest that the death signal induced by NGF withdrawal is mediated at least in part via the ASK1-JNK pathway in neurons.
ASK1 is required for Cdc42-induced death. Recently, we have shown that NGF withdrawal-induced death requires the activity of the small GTP-binding protein Cdc42 and that overexpression of an active form of Cdc42 is sufficient to mediate neuronal apoptosis via activation of the c-Jun pathway (1). To determine whether ASK1 and Cdc42 lie on the same pathway, we coinjected an activated mutant of Cdc42 (V12Cdc42) and the kinase-inactive mutant ASK1-KR into SCG neurons. The cells were maintained in the presence of NGF, and the percent survival was determined 48 h after injection. Figure 6A shows that blocking ASK1 activity was sufficient to rescue SCG neurons from Cdc42-induced cell death. Furthermore, we investigated the effect of ASK1-KR on the activation of the JNK pathway by V12Cdc42. SCG neurons were injected as described above and stained with a specific anti-phospho-c-Jun antibody 24 h later. Coexpression of ASK1-KR significantly reversed the induction of phosphorylation of c-Jun by an activated mutant of Cdc42. These results suggest that ASK1 acts as a downstream mediator of Cdc42 in SCG neurons.
DISCUSSION
In sympathetic neurons and in differentiated PC12 cells, activation of the c-Jun pathway plays an important role in the induction of apoptosis by NGF deprivation (9, 14, 38) . Recently, we showed that the small GTP-binding protein Cdc42 functions as an initiator of neuronal apoptosis via regulation of this pathway (1) . In an attempt to identify a mediator of neuronal apoptosis induced by NGF withdrawal that would also lie on the Cdc42-JNK pathway, we examined the role of ASK1. ASK1 is a newly identified MAPKKK and has been reported to FIG. 6 . Effect of a dominant negative ASK1 on Cdc42-induced cell death. (A) Cdc42-induced apoptosis requires ASK1 activity. We coinjected 0.3 or 0.5 mg of ASK1-KR per ml, 0.1 mg of V12Cdc42 per ml, and 70-kDa Texas Reddextran into SCG neurons. The cells were maintained in the presence of NGF, and the percentage of surviving cells was assessed 48 h after injection as previously described. The results are the means and standard errors of the mean of three independent experiments. ASK1-KR blocks Cdc42-induced death. The P value of ASK1-KR is Ͻ0.01 at 0.3 mg/ml and Ͻ0.001 at 0.5 mg/ml. (B) ASK1-KR blocks Cdc42-induced increase of phosphorylation of c-Jun. SCG neurons were coinjected with 0.5 mg of ASK1-KR per ml and 0.1 mg of V12Cdc42 per ml together with 5 mg of guinea pig IgG per ml to detect the injected cells and maintained in the presence of NGF. The cells were stained 24 h later with a specific anti-phospho-c-Jun antibody. The results are the means and standard errors of the mean of three independent experiments. The P value of ASK1-KR at 0.5 mg/ml is Ͻ0.01.
activate the JNK pathway and to induce apoptosis in a variety of cell types (4, 18, 27) for the tumor necrosis factor alpha-and Fas-induced JNK pathways (4, 24) .
To study its role in NGF withdrawal and Cdc42-induced cell death, we have overexpressed a constitutively active mutant of ASK1 (ASK1-⌬N) in the PC12 cell line and rat SCG neurons. ASK1-⌬N induced a significant decrease in cell viability (Fig.  1) , and this death exhibited the characteristics of apoptosis, with the cells displaying pyknotic nuclei, DNA fragmentation, shrinkage, and membrane blebbing ( Fig. 1 and data not  shown) . More importantly, kinase-inactive mutants of ASK1, which act as dominant interfering mutants, significantly blocked NGF withdrawal-induced death ( Fig. 2 and 3 ) demonstrating that ASK1 is a crucial element of neuronal apoptosis induced by neurotrophic factor deprivation.
ASK1 activity peaked at 3 h after NGF withdrawal in differentiated PC12 cells (Fig. 4) ; this would precede the peak of JNK activity and the increase in c-Jun protein levels. Indeed, JNK activity peaks between 4 and 8 h under the same conditions, at the time when the levels of c-Jun proteins are at their highest (8, 14) . Consistent with this, we found that activated ASK1 induced an activation of JNK in PC12 cells (Fig. 5A and B) and an increase in the level of phosphorylated c-Jun and of its transcriptional activity in SCG neurons (Fig. 5C and D) . More importantly, we found that a dominant negative mutant of ASK1, ASK1-KR, blocked the activation of JNK and of c-jun induced by NGF deprivation (Fig. 5C and D) .
Although SEK1 has been shown to be activated by ASK1, a dominant negative mutant of SEK1, SEK-AL, could not block ASK1-induced death (data not shown) in SCGs. It has been previously shown that SEK-AL could not block NGF withdrawal-or Cdc42-induced death in SCG neurons (reference 8 and data not shown). Although we cannot rule out completely the involvement of SEK1 in neuronal apoptosis, it appears that there must be an additional JNKK activated by Cdc42 or by ASK1. In this regard, a recently identified JNKK termed MKK7 might be the target of ASK1 in SCGs (11, 17, 20, 22, 32, 33) . This possibility remains to be confirmed. In addition, the p38 kinase pathway is not activated in SCG neurons after NGF deprivation (8) , and therefore we believe that ASK1 is initiating cell death via regulation of the JNK pathway only in these cells. This is confirmed by the fact that a dominant negative mutant of c-Jun, FLAG⌬169, blocked the ASK1-induction of cell death in SCG neurons (Fig. 5E) . Figure 7 represents our current model of NGF withdrawalinduced cell death-signalling pathways in neurons. Although MEKK1 but not ASK1 is likely to be involved in Cdc42-induced JNK activation in COS-7 cells (2), ASK1 is required for Cdc42 to induce apoptosis in SCG neurons. Once activated by NGF withdrawal, ASK1 may induce neuronal apoptosis through the JNK-c-Jun pathway.
In conclusion, we have identified ASK1 as another crucial element of the signalling mechanism of neuronal cell death induced by neurotrophic factor withdrawal.
